Skip to main content
See every side of every news story
Published loading...Updated

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026

AbbVie trades at a forward P/E of 15.9 and Merck at 10.5, both offering durable dividends and strategic pipelines to offset franchise pressures.

Summary by The Motley Fool
Key PointsOne of these pharmaceutical leaders overcame a major obstacle and has a strong outlook.The other is actively pushing greater innovation to get around a rapidly approaching patent cliff. They both look reasonably valued and are solid dividend-paying corporations. 10 stocks we like better than AbbVie › Looking for great stocks to be had at a bargain? Even though broader equities have performed well this year, there are companies, particu…

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Friday, December 12, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal